Navigation Links
Prestigious $4.9 million NIH grant awarded to Case Western Reserve for colon cancer research

A prestigious National Institutes of Health (NIH) Transformative R01 Program grant for $4.9 million has been awarded to Case Western Reserve University School of Medicine. The five-year grant will fund research to identify patients' inborn genetic susceptibility to the development of colon cancer metastasis. Case Western Reserve was one of only 42 recipients of this competitive new grant designed to support exceptionally innovative, high risk, original and/or unconventional research projects that have the potential to create or overturn fundamental paradigms.

"The distinction of being selected for this award reflects the leading role played by Case Western Reserve University School of Medicine and the University Hospitals Ireland Cancer Center at the national level," says Sanford Markowitz, M.D., Ph.D., the study's principal investigator and the Markowitz-Ingalls Professor of Cancer Genetics.

Colon cancer is the second leading cause of cancer deaths in the United States. One third of individuals with colon cancer die of a metastatic spread of the disease. The School of Medicine team proposes there is a new paradigm in colon cancer metastasis, which has historically thought to be due to the accumulation of multiple gene mutations in the cancer cell. Dr. Markowitz and team hypothesize that cancer metastasis is not due to new "metastasis-causing" genetic mutations in the cancers, but rather is crucially dependent on inborn genetic susceptibility factors. This proposal is based on the team's prior research studies showing that no new mutations acquired in a colon cancer metastases are any different from the preceding primary colon cancer tumor. These findings directly challenge the paradigm that has dominated cancer genetics for more than two decades.

Specifically, the team will identify these susceptibility genetic markers using the technique of a whole genome association study to compare the frequency of more than one million genetic variants between individuals whose colon cancers never metastasized, versus those whose colon cancers were metastatic at the time of diagnosis, and versus individuals whose colon cancers relapsed and metastasized following initial complete surgical resections. By identifying genetic markers that track with individuals who have developed cancer metastases, the team will seek to hone in on and identify the underlying metastasis susceptibility genes; identify the causative metastasis susceptibility variants present in these genes among different ethnic groups; determine if these variants or genes also impart susceptibility to metastasis in other common solid tumors; and determine the biologic pathways by which these susceptibility alleles promote cancer metastasis.

Acceptance of this paradigm will result in the identification of entirely new biological pathways that will be key to the management and prognosis of colon cancer, and to developing new and more effective anti-cancer therapies.


Contact: Jessica Studeny
Case Western Reserve University

Related biology news :

1. IGC scientist awarded prestigious European Research Council Starting grant
2. Academy Library accepted to prestigious Biodiversity Heritage Library
3. Shaw to receive prestigious honor for plant pathology research
4. Springer Series editor John Smol receives two prestigious biology awards
5. Pest management specialist Charles Summers wins prestigious Woodworth Award
6. 2 McGill researchers garner prestigious NSERC Steacie Fellowships
7. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 13 top young investigators
8. High school students paper published in prestigious college math journal
9. Chemistry professor 1 of only 3 at UH to achieve prestigious AAAS status
10. HJF nursing specialist wins prestigious Celina Field Cargiver Award
11. Halas wins prestigious nanotechnology research award
Post Your Comments:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... June 23, 2016 Houston Methodist Willowbrook ... Cy-Fair Sports Association to serve as their official ... Houston Methodist Willowbrook will provide sponsorship support, athletic ... with association coaches, volunteers, athletes and families. ... Cy-Fair Sports Association and to bring Houston Methodist ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
Breaking Biology Technology: